×




Pharmaceutical Industry: Challenges in the New Century SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

Case Study SWOT Analysis Solution

Case Study Description of Pharmaceutical Industry: Challenges in the New Century


Provides a broad overview of the numerous internal and external forces that were driving change in the global pharmaceutical industry in 2003. These forces--including downward price pressures, political and social pressures, increased development costs, new technologies, new and different competitors, consolidation, and threats to its basic business models--were changing the way drugs were discovered, developed, manufactured, tested, regulated, marketed, sold, and purchased. A rewritten version of an earlier case.

Authors :: Stephen P. Bradley, James Weber

Topics :: Strategy & Execution

Tags :: Competition, SWOT Analysis, SWOT Matrix, TOWS, Weighted SWOT Analysis

Swot Analysis of "Pharmaceutical Industry: Challenges in the New Century" written by Stephen P. Bradley, James Weber includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Pressures Forces facing as an external strategic factors. Some of the topics covered in Pharmaceutical Industry: Challenges in the New Century case study are - Strategic Management Strategies, Competition and Strategy & Execution.


Some of the macro environment factors that can be used to understand the Pharmaceutical Industry: Challenges in the New Century casestudy better are - – supply chains are disrupted by pandemic , wage bills are increasing, geopolitical disruptions, talent flight as more people leaving formal jobs, increasing government debt because of Covid-19 spendings, competitive advantages are harder to sustain because of technology dispersion, digital marketing is dominated by two big players Facebook and Google, increasing commodity prices, increasing transportation and logistics costs, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of Pharmaceutical Industry: Challenges in the New Century


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Pharmaceutical Industry: Challenges in the New Century case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Pressures Forces, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Pressures Forces operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of Pharmaceutical Industry: Challenges in the New Century can be done for the following purposes –
1. Strategic planning using facts provided in Pharmaceutical Industry: Challenges in the New Century case study
2. Improving business portfolio management of Pressures Forces
3. Assessing feasibility of the new initiative in Strategy & Execution field.
4. Making a Strategy & Execution topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Pressures Forces




Strengths Pharmaceutical Industry: Challenges in the New Century | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of Pressures Forces in Pharmaceutical Industry: Challenges in the New Century Harvard Business Review case study are -

Ability to lead change in Strategy & Execution field

– Pressures Forces is one of the leading players in its industry. Over the years it has not only transformed the business landscape in its segment but also across the whole industry. The ability to lead change has enabled Pressures Forces in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.

Sustainable margins compare to other players in Strategy & Execution industry

– Pharmaceutical Industry: Challenges in the New Century firm has clearly differentiated products in the market place. This has enabled Pressures Forces to fetch slight price premium compare to the competitors in the Strategy & Execution industry. The sustainable margins have also helped Pressures Forces to invest into research and development (R&D) and innovation.

Low bargaining power of suppliers

– Suppliers of Pressures Forces in the sector have low bargaining power. Pharmaceutical Industry: Challenges in the New Century has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Pressures Forces to manage not only supply disruptions but also source products at highly competitive prices.

Highly skilled collaborators

– Pressures Forces has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive segment. Secondly the value chain collaborators of the firm in Pharmaceutical Industry: Challenges in the New Century HBR case study have helped the firm to develop new products and bring them quickly to the marketplace.

Superior customer experience

– The customer experience strategy of Pressures Forces in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.

Cross disciplinary teams

– Horizontal connected teams at the Pressures Forces are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.

Operational resilience

– The operational resilience strategy in the Pharmaceutical Industry: Challenges in the New Century Harvard Business Review case study comprises – understanding the underlying the factors in the industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.

Analytics focus

– Pressures Forces is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Stephen P. Bradley, James Weber can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.

High brand equity

– Pressures Forces has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Pressures Forces to keep acquiring new customers and building profitable relationship with both the new and loyal customers.

Training and development

– Pressures Forces has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in Pharmaceutical Industry: Challenges in the New Century Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.

Digital Transformation in Strategy & Execution segment

- digital transformation varies from industry to industry. For Pressures Forces digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Pressures Forces has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.

Learning organization

- Pressures Forces is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Pressures Forces is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Pharmaceutical Industry: Challenges in the New Century Harvard Business Review case study emphasize – knowledge, initiative, and innovation.






Weaknesses Pharmaceutical Industry: Challenges in the New Century | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of Pharmaceutical Industry: Challenges in the New Century are -

Low market penetration in new markets

– Outside its home market of Pressures Forces, firm in the HBR case study Pharmaceutical Industry: Challenges in the New Century needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.

Slow decision making process

– As mentioned earlier in the report, Pressures Forces has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Pressures Forces even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.

High dependence on existing supply chain

– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Pressures Forces supply chain. Even after few cautionary changes mentioned in the HBR case study - Pharmaceutical Industry: Challenges in the New Century, it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Pressures Forces vulnerable to further global disruptions in South East Asia.

Employees’ incomplete understanding of strategy

– From the instances in the HBR case study Pharmaceutical Industry: Challenges in the New Century, it seems that the employees of Pressures Forces don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.

Compensation and incentives

– The revenue per employee as mentioned in the HBR case study Pharmaceutical Industry: Challenges in the New Century, is just above the industry average. Pressures Forces needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.

Need for greater diversity

– Pressures Forces has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.

Aligning sales with marketing

– It come across in the case study Pharmaceutical Industry: Challenges in the New Century that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case Pharmaceutical Industry: Challenges in the New Century can leverage the sales team experience to cultivate customer relationships as Pressures Forces is planning to shift buying processes online.

High operating costs

– Compare to the competitors, firm in the HBR case study Pharmaceutical Industry: Challenges in the New Century has high operating costs in the. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Pressures Forces 's lucrative customers.

Increasing silos among functional specialists

– The organizational structure of Pressures Forces is dominated by functional specialists. It is not different from other players in the Strategy & Execution segment. Pressures Forces needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help Pressures Forces to focus more on services rather than just following the product oriented approach.

High dependence on star products

– The top 2 products and services of the firm as mentioned in the Pharmaceutical Industry: Challenges in the New Century HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Pressures Forces has relatively successful track record of launching new products.

High bargaining power of channel partners

– Because of the regulatory requirements, Stephen P. Bradley, James Weber suggests that, Pressures Forces is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.




Opportunities Pharmaceutical Industry: Challenges in the New Century | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities highlighted in the Harvard Business Review case study Pharmaceutical Industry: Challenges in the New Century are -

Changes in consumer behavior post Covid-19

– Consumer behavior has changed in the Strategy & Execution industry because of Covid-19 restrictions. Some of this behavior will stay once things get back to normal. Pressures Forces can take advantage of these changes in consumer behavior to build a far more efficient business model. For example consumer regular ordering of products can reduce both last mile delivery costs and market penetration costs. Pressures Forces can further use this consumer data to build better customer loyalty, provide better products and service collection, and improve the value proposition in inflationary times.

Learning at scale

– Online learning technologies has now opened space for Pressures Forces to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.

Loyalty marketing

– Pressures Forces has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Use of Bitcoin and other crypto currencies for transactions

– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Pressures Forces in the consumer business. Now Pressures Forces can target international markets with far fewer capital restrictions requirements than the existing system.

Manufacturing automation

– Pressures Forces can use the latest technology developments to improve its manufacturing and designing process in Strategy & Execution segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Creating value in data economy

– The success of analytics program of Pressures Forces has opened avenues for new revenue streams for the organization in the industry. This can help Pressures Forces to build a more holistic ecosystem as suggested in the Pharmaceutical Industry: Challenges in the New Century case study. Pressures Forces can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.

Identify volunteer opportunities

– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Pressures Forces can explore opportunities that can attract volunteers and are consistent with its mission and vision.

Redefining models of collaboration and team work

– As explained in the weaknesses section, Pressures Forces is facing challenges because of the dominance of functional experts in the organization. Pharmaceutical Industry: Challenges in the New Century case study suggests that firm can utilize new technology to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.

Using analytics as competitive advantage

– Pressures Forces has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Pharmaceutical Industry: Challenges in the New Century - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Pressures Forces to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.

Reconfiguring business model

– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Pressures Forces to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.

Building a culture of innovation

– managers at Pressures Forces can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Strategy & Execution segment.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects Pressures Forces can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Lowering marketing communication costs

– 5G expansion will open new opportunities for Pressures Forces in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Strategy & Execution segment, and it will provide faster access to the consumers.




Threats Pharmaceutical Industry: Challenges in the New Century External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats mentioned in the HBR case study Pharmaceutical Industry: Challenges in the New Century are -

Learning curve for new practices

– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study Pharmaceutical Industry: Challenges in the New Century, Pressures Forces may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Strategy & Execution .

Increasing international competition and downward pressure on margins

– Apart from technology driven competitive advantage dilution, Pressures Forces can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate prominent markets illustrated in HBR case study Pharmaceutical Industry: Challenges in the New Century .

High dependence on third party suppliers

– Pressures Forces high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Pressures Forces.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Pressures Forces with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.

Stagnating economy with rate increase

– Pressures Forces can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.

Environmental challenges

– Pressures Forces needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Pressures Forces can take advantage of this fund but it will also bring new competitors in the Strategy & Execution industry.

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Pressures Forces will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

Easy access to finance

– Easy access to finance in Strategy & Execution field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Pressures Forces can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.

Regulatory challenges

– Pressures Forces needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Strategy & Execution industry regulations.

New competition

– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Pressures Forces in the Strategy & Execution sector and impact the bottomline of the organization.

Trade war between China and United States

– The trade war between two of the biggest economies can hugely impact the opportunities for Pressures Forces in the Strategy & Execution industry. The Strategy & Execution industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Pressures Forces needs to understand the core reasons impacting the Strategy & Execution industry. This will help it in building a better workplace.




Weighted SWOT Analysis of Pharmaceutical Industry: Challenges in the New Century Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Pharmaceutical Industry: Challenges in the New Century needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of the case study Pharmaceutical Industry: Challenges in the New Century is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of the Harvard case study Pharmaceutical Industry: Challenges in the New Century is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of Pharmaceutical Industry: Challenges in the New Century is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Pressures Forces needs to make to build a sustainable competitive advantage.



--- ---

A Costly Train Journey (B) SWOT Analysis / TOWS Matrix

N. Craig Smith, Elin Williams , Leadership & Managing People


Fotolia N.A.: Acting like a Start-Up in a Mature Industry SWOT Analysis / TOWS Matrix

Rebecca A. Grant, David M. McCutcheon , Technology & Operations


Discovery Health (B) SWOT Analysis / TOWS Matrix

Samuel Chun, Shaun Matisonn , Sales & Marketing


The Lump Sum Grant Initiative for Hong Kong Social Services SWOT Analysis / TOWS Matrix

Howard Husock, Herman Leonard , Leadership & Managing People